Have questions? Visit https://www.reddit.com/r/SNPedia

rs705381

From SNPedia

Orientationplus
Stabilizedplus
Geno Mag Summary
(C;C) normal
(C;T) less likely to gain weight if taking risperidone
(T;T) less likely to gain weight if taking risperidone
ReferenceGRCh38 38.1/141
Chromosome7
Position95324637
GenePON1
is asnp
is mentioned by
dbSNPrs705381
dbSNP (classic)rs705381
ClinGenrs705381
ebirs705381
HLIrs705381
Exacrs705381
Gnomadrs705381
Varsomers705381
LitVarrs705381
Maprs705381
PheGenIrs705381
Biobankrs705381
1000 genomesrs705381
hgdprs705381
ensemblrs705381
geneviewrs705381
scholarrs705381
googlers705381
pharmgkbrs705381
gwascentralrs705381
openSNPrs705381
23andMers705381
SNPshotrs705381
SNPdbers705381
MSV3drs705381
GWAS Ctlgrs705381
GMAF0.2388
Max Magnitude0
? (C;C) (C;T) (T;T) 28


rs705381, also known as -161C/T and -162A/G, is a SNP in the upstream promoter region of the PON1 gene. (The assumption of equivalence between these names is based on the results of searching for rs705381 in the Variant Name Mapper.)

[PMID 17199131] In a study of 101 mostly Caucasian patients prescribed the atypical antipsychotic risperidone, carriers of a rs705381(C) allele were less likely to gain significant weight compared to rs705381(T;T) carriers, as assessed by physiogenomic analysis of corresponding weight profiles. Two other SNPs, rs8179183 and rs6837793, were also significantly associated with weight profiles in these patients.

[PMID 15060281)] In a study of 461 participants in the HERITAGE cohort (172 African-American, 289 Caucasian), the combination of rs705381 with "PON-126" (RS ID unknown) were found to significantly contribute to trait-anxiety scores. The authors also cite another paper, [PMID 12525679], which found that this SNP accounts for 2.4% of the variation in PON1 expression. Which allele correlates with increased trait-anxiety scores and/or reduced PON1 expression is unclear.

HapMap frequencies for this SNP seem dubious. They list rs705381(T;T) as being at or near 100% for the population groups reported by SNPedia. However, the raw data at HapMap for this SNP are largely no-call (e.g. CEU: NN=87, TT=82, CT=3). The other diversity studies listed at dbSNP show C as the more common allele (e.g. AFD_AFR_PANEL: CC=47.8%, CT=39.1%, TT=13.0%). Anecdotal data submitted by participants at 23andme also show C as being more common (CC=4, CT=1, TT=2). The diversity data have therefore been removed until these discrepancies can be resolved.

[PMID 18618303OA-icon.png] A common haplotype within the PON1 promoter region is associated with sporadic ALS.

[PMID 19321847OA-icon.png] A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS.

[PMID 21223581OA-icon.png] Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus.


[PMID 23356507OA-icon.png] Association between paraoxonase gene and stroke in the Han Chinese population


[PMID 24448003] Methylmercury exposure, PON1 gene variants and serum paraoxonase activity in Eastern James Bay Cree adults


[PMID 22884547] Association analysis of PON polymorphisms in sporadic ALS in a Chinese population.


[PMID 22956172OA-icon.png] Regulatory regions of the paraoxonase 1 (PON1) gene are associated with neovascular age-related macular degeneration (AMD).